•  
  •  
  •  
  •  

2025-05-09 15:21:41

  • Home
  • Commodities
  • Industry News
  • IPO
  • Mutual Funds
  • Others
  • Research
  • Watch List
Latest News
  • Lemon Tree Hotels launches its 4th property in Goa with Lemon Tree Hotel, Anjuna
  • Route Mobile Ltd Q4 FY25 consolidated net profit falls to Rs. 56.58 crores
  • Star Housing Finance Ltd Q4 FY2024-25 PAT up at Rs. 2.97 crore
  • Linc Ltd Q4FY25 consolidated PAT higher at Rs. 12.10 crores
  • EKI Energy Services Ltd Q4 FY2025 consolidated loss at Rs. 6.24 crore

Keywords Selected:  FinalApproval

Stock Report

  • Alembic Pharmaceuticals Ltd announces USFDA Final Approval for Ticagrelor Tablets, 90 mg and Tentative Approval for Ticagrelor Tablets, 60 mg
  • Eugia Pharma receives USFDA Approval for Dasatinib Tablets
  • Caplin Steriles Ltd gets USFDA approval for Phytonadione Injectable Emulsion
  • Alembic Pharmaceuticals receives USFDA Final Approval for Carbamazepine Tablets USP, 200 mg
  • Royal Sense Limited receives final approval from USFDA for products
  • Bliss GVS Pharma Ltd's partner gets final approval from USFDA for Mesalamine Suppositories 1000 mg
  • Aurobindo Pharma receives final ANDA approval for Rivaroxaban Tablets USP, 2.5mg
  • Cipla Limited receives USFDA final approval for ANDA Protein-bound Paclitaxel
  • Concord Biotech Limited receives final approval from USFDA for Teriflunomide Tablets
  • Alembic Pharmaceuticals Ltd announces USFDA Final Approval for Pantoprazole Sodium for Injection, 40 mg/vial - Single-Dose Vial
  • Zydus receives final approval from USFDA for Apalutamide Tablets, 60 mg
  • Zydus receives final approval from USFDA for Eluxadoline Tablets, 75 mg and 100 mg
  • Lupin Launches Rivaroxaban Tablets USP, 2.5mg in the United States
  • Zydus receives final approval from USFDA for Ibuprofen and Famotidine Tablets, 800 mg/26.6 mg
  • Caplin Steriles gets USFDA approval for Levetiracetam in Sodium Chloride Injection, Infusion Bags
  • Alembic Pharmaceuticals Ltd announces USFDA Final Approval for Divalproex Sodium Delayed-Release Capsules USP, 125 mg
  • Zydus receives final approval from USFDA for Lidocaine and Prilocaine Cream USP, 2.5%/2.5%
  • FDC Ltd receives final approval from USFDA for ANDA Cefixime 400 mg Tablets
  • Caplin Steriles gets USFDA approval for Difluprednate Ophthalmic Emulsion
  • Eugia Pharma receives USFDA Approval for Pazopanib Tablets, 200 mg
  • Alembic Pharmaceuticals announces USFDA Final Approval for Diltiazem Hydrochloride Extended-Release Capsules USP, 120 mg, 180 mg, and 240 mg
  • Zydus receives final approval from USFDA for Fludrocortisone Acetate Tablets USP, 0.1 mg
  • Zydus receives final approval from USFDA for Paliperidone Extended-Release Tablets, 1.5 mg, 3 mg, 6 mg and 9 mg
  • Indoco Remedies receives final ANDA approval from the USFDA for Cetirizine Hydrochloride Tablets USP, 10 mg OTC

Latest Post

  • Lemon Tree Hotels launches its 4th property in Goa with Lemon Tree Hotel, Anjuna
  • Route Mobile Ltd Q4 FY25 consolidated net profit falls to Rs. 56.58 crores
  • Star Housing Finance Ltd Q4 FY2024-25 PAT up at Rs. 2.97 crore
  • Linc Ltd Q4FY25 consolidated PAT higher at Rs. 12.10 crores
  • EKI Energy Services Ltd Q4 FY2025 consolidated loss at Rs. 6.24 crore


Announcement

To Advertise in our website please e-mail us at advertisement@equitybulls.com
Companies can send their Press Releases to pressrelease@equitybulls.com

Links

  • Home
  • Contact
  • Our Team

Contact

The website is developed and maintained by Chennai Scripts
C-4, Podhigai Flats, Pillayar Koil Street, Nesapakkam
Chennai
Tamil Nadu
India
600078
E-mail: chennaiscripts@gmail.com
Mobile Phone Number: +91-88776-69935
www.chennaiscripts.com

Website Created & Maintained by : Chennai Scripts
Nesapakkam, Chennai - 600 078,
Tamil Nadu, India

Disclaimer Copyright © - 2024